mercaptoethanol has been researched along with Carcinoma, Small Cell in 4 studies
Mercaptoethanol: A water-soluble thiol derived from hydrogen sulfide and ethanol. It is used as a reducing agent for disulfide bonds and to protect sulfhydryl groups from oxidation.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (75.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Banham, S | 1 |
Soukop, M | 1 |
Burnett, A | 1 |
Stevenson, R | 1 |
Cunningham, D | 1 |
Tansey, P | 1 |
Ahmedzai, S | 1 |
Stack, B | 1 |
Dorward, A | 1 |
Lucie, N | 1 |
Holoye, PY | 1 |
Glisson, BS | 1 |
Lee, JS | 1 |
Dhingra, HM | 1 |
Murphy, WK | 1 |
Umsawasdi, T | 1 |
Levy, JK | 1 |
Jeffries, D | 1 |
Raber, MN | 1 |
Hong, WK | 1 |
Cantwell, BM | 2 |
Harris, AL | 2 |
Bozzino, JM | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
A Phase Ⅱ Randomized Clinical Trial Comparing Vinorelbine-ifosfamide With Gefitinib as Third-line Treatment in Advanced EGFR Gene Mutation Negative Non-small Cell Lung Cancer Patients[NCT01749072] | Phase 2 | 120 participants (Anticipated) | Interventional | 2012-12-31 | Recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 trial available for mercaptoethanol and Carcinoma, Small Cell
Article | Year |
---|---|
Experience with 24-h infusions of ifosfamide/mesna in small cell lung cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Drug Evaluation; Humans; Ifos | 1986 |
3 other studies available for mercaptoethanol and Carcinoma, Small Cell
Article | Year |
---|---|
Treatment of small cell carcinoma of lung with late dosage intensification programmes containing cyclophosphamide and mesna.
Topics: Adult; Aged; Carcinoma, Small Cell; Cyclophosphamide; Drug Therapy, Combination; Female; Humans; Lun | 1983 |
Ifosfamide with mesna uroprotection in the management of lung cancer.
Topics: Aged; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Female; Humans | 1990 |
Ifosfamide/mesa and encephalopathy.
Topics: Brain Diseases; Carcinoma, Small Cell; Cyclophosphamide; Female; Humans; Ifosfamide; Lung Neoplasms; | 1985 |